Elevance Health Debt to Equity Ratio 2010-2025 | ELV
Current and historical debt to equity ratio values for Elevance Health (ELV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Elevance Health debt/equity for the three months ending March 31, 2025 was 0.66.
| Elevance Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $77.10B | $42.62B | 1.81 |
| 2024-12-31 | $75.46B | $41.43B | 1.82 |
| 2024-09-30 | $72.65B | $43.88B | 1.66 |
| 2024-06-30 | $70.69B | $42.30B | 1.67 |
| 2024-03-31 | $71.18B | $40.71B | 1.75 |
| 2023-12-31 | $69.52B | $39.41B | 1.76 |
| 2023-09-30 | $71.94B | $38.54B | 1.87 |
| 2023-06-30 | $70.86B | $38.31B | 1.85 |
| 2023-03-31 | $71.58B | $37.46B | 1.91 |
| 2022-12-31 | $66.43B | $36.33B | 1.83 |
| 2022-09-30 | $66.98B | $36.04B | 1.86 |
| 2022-06-30 | $65.01B | $35.87B | 1.81 |
| 2022-03-31 | $64.46B | $36.03B | 1.79 |
| 2021-12-31 | $61.33B | $36.13B | 1.70 |
| 2021-09-30 | $62.25B | $35.81B | 1.74 |
| 2021-06-30 | $61.05B | $35.05B | 1.74 |
| 2021-03-31 | $61.77B | $33.92B | 1.82 |
| 2020-12-31 | $53.42B | $33.20B | 1.61 |
| 2020-09-30 | $52.65B | $33.92B | 1.55 |
| 2020-06-30 | $53.52B | $34.46B | 1.55 |
| 2020-03-31 | $50.71B | $31.69B | 1.60 |
| 2019-12-31 | $45.73B | $31.73B | 1.44 |
| 2019-09-30 | $46.48B | $31.33B | 1.48 |
| 2019-06-30 | $45.06B | $30.79B | 1.46 |
| 2019-03-31 | $44.53B | $30.00B | 1.48 |
| 2018-12-31 | $43.03B | $28.54B | 1.51 |
| 2018-09-30 | $45.35B | $29.09B | 1.56 |
| 2018-06-30 | $45.64B | $28.73B | 1.59 |
| 2018-03-31 | $46.29B | $27.01B | 1.71 |
| 2017-12-31 | $44.04B | $26.50B | 1.66 |
| 2017-09-30 | $42.36B | $25.95B | 1.63 |
| 2017-06-30 | $41.81B | $26.43B | 1.58 |
| 2017-03-31 | $42.85B | $26.09B | 1.64 |
| 2016-12-31 | $39.98B | $25.10B | 1.59 |
| 2016-09-30 | $39.66B | $24.74B | 1.60 |
| 2016-06-30 | $39.83B | $24.23B | 1.64 |
| 2016-03-31 | $40.31B | $23.55B | 1.71 |
| 2015-12-31 | $38.67B | $23.04B | 1.68 |
| 2015-09-30 | $39.10B | $23.24B | 1.68 |
| 2015-06-30 | $41.20B | $23.06B | 1.79 |
| 2015-03-31 | $41.21B | $24.33B | 1.69 |
| 2014-12-31 | $37.43B | $24.25B | 1.54 |
| 2014-09-30 | $37.76B | $24.29B | 1.55 |
| 2014-06-30 | $37.93B | $24.38B | 1.56 |
| 2014-03-31 | $37.34B | $24.35B | 1.53 |
| 2013-12-31 | $34.81B | $24.77B | 1.41 |
| 2013-09-30 | $35.46B | $24.81B | 1.43 |
| 2013-06-30 | $35.08B | $24.53B | 1.43 |
| 2013-03-31 | $35.09B | $24.32B | 1.44 |
| 2012-12-31 | $35.15B | $23.80B | 1.48 |
| 2012-09-30 | $32.00B | $23.82B | 1.34 |
| 2012-06-30 | $30.89B | $23.64B | 1.31 |
| 2012-03-31 | $28.97B | $23.53B | 1.23 |
| 2011-12-31 | $28.88B | $23.29B | 1.24 |
| 2011-09-30 | $28.83B | $23.72B | 1.22 |
| 2011-06-30 | $26.70B | $24.18B | 1.10 |
| 2011-03-31 | $26.94B | $23.98B | 1.12 |
| 2010-12-31 | $26.35B | $23.81B | 1.11 |
| 2010-09-30 | $26.67B | $24.36B | 1.10 |
| 2010-06-30 | $26.37B | $23.79B | 1.11 |
| 2010-03-31 | $26.66B | $24.52B | 1.09 |
| 2009-12-31 | $27.26B | $24.86B | 1.10 |
| 2009-09-30 | $26.63B | $22.87B | 1.17 |
| 2009-06-30 | $27.09B | $22.25B | 1.22 |
| 2009-03-31 | $27.91B | $21.51B | 1.30 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $86.192B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.275B | 26.68 |
| CVS Health (CVS) | United States | $86.641B | 10.77 |
| Cencora (COR) | United States | $58.035B | 20.19 |
| DiDi Global (DIDIY) | China | $23.015B | 24.45 |
| Natera (NTRA) | United States | $22.934B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.811B | 17.69 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.798B | 0.00 |
| Solventum (SOLV) | United States | $13.056B | 13.82 |
| CochLear (CHEOY) | Australia | $12.649B | 0.00 |
| ICON (ICLR) | Ireland | $11.674B | 10.85 |
| Revvity (RVTY) | United States | $11.530B | 19.84 |
| Viatris (VTRS) | United States | $10.575B | 3.63 |
| Avantor (AVTR) | United States | $9.220B | 13.40 |
| HealthEquity (HQY) | United States | $9.070B | 39.73 |
| Medpace Holdings (MEDP) | United States | $8.930B | 23.72 |
| Sonic Healthcare (SKHHY) | Australia | $8.455B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.368B | 14.44 |
| Caris Life Sciences,�Inc (CAI) | $6.821B | 0.00 | |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.386B | 25.83 |
| BrightSpring Health Services (BTSG) | United States | $4.138B | 37.97 |
| Sotera Health (SHC) | United States | $3.213B | 18.26 |
| Surgery Partners (SGRY) | United States | $2.813B | 36.58 |
| Alignment Healthcare (ALHC) | United States | $2.740B | 0.00 |
| Concentras Parent (CON) | United States | $2.711B | 15.67 |
| GeneDx Holdings (WGS) | United States | $2.599B | 100.11 |
| Organon (OGN) | United States | $2.563B | 2.72 |
| PACS (PACS) | United States | $1.980B | 0.00 |
| Ardent Health (ARDT) | United States | $1.957B | 8.34 |
| Progyny (PGNY) | United States | $1.878B | 41.34 |
| Premier (PINC) | United States | $1.779B | 13.51 |
| GoodRx Holdings (GDRX) | United States | $1.750B | 35.00 |
| Teladoc Health (TDOC) | United States | $1.475B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.205B | 9.17 |
| Establishment Labs Holdings (ESTA) | $1.184B | 0.00 | |
| CareDx (CDNA) | United States | $1.071B | 16.72 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.799B | 7.48 |
| Nutex Health (NUTX) | United States | $0.683B | 10.34 |
| LifeMD (LFMD) | United States | $0.625B | 0.00 |
| Embecta (EMBC) | United States | $0.563B | 3.80 |
| InnovAge Holding (INNV) | United States | $0.529B | 0.00 |
| Enhabit (EHAB) | United States | $0.484B | 39.83 |
| SBC Medicals (SBC) | United States | $0.481B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
| Omada Health (OMDA) | $0.453B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.313B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.259B | 0.00 |
| Beauty Health (SKIN) | United States | $0.246B | 0.00 |
| So-Young (SY) | China | $0.240B | 0.00 |
| Oncology Institute (TOI) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.163B | 26.67 |
| Sera Prognostics (SERA) | United States | $0.154B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.120B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.032B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |